Evidence map›Paper›PMID 41372746›Full record

ArticleBMC neuroscience2025

Guanidino compounds with native GABA(A) δ receptor selectivity: a tale of homeostatic compensation in δ-KO mice.

Pratap Meera, Mikko Uusi-Oukari, Martin Wallner, Gerald S Lipshutz

Abstract read
In one paragraph

Article in BMC neuroscience, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Pratap MeeraDepartment of Neurobiology, University of California, Los Angeles, CA, 90095, USA.ORCID 0000-0001-9483-6690
Mikko Uusi-OukariIntegrative Physiology and Pharmacology, Institute of Biomedicine, University of Turku, Turku, FIN-20014, Finland.ORCID 0000-0003-1756-4577
Martin WallnerDepartment of Surgery, University of California, 635 Charles E. Young Dr. S., NRB 379D, Los Angeles, CA, 90095, USA. mwallner@g.ucla.edu.ORCID 0000-0003-4134-8946
Gerald S LipshutzDepartment of Surgery, University of California, 635 Charles E. Young Dr. S., NRB 379D, Los Angeles, CA, 90095, USA. GLipshutz@mednet.ucla.edu.ORCID 0000-0001-7876-6776

Funding

UCLA IDDRC: Translational CoreP50HD103557 · NICHD · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI Peyman Golshani, SUMA JACOB · 2020 to 2026
$9.6M
Understanding the Mechanism and Preventing the Unique Neuropathology of Arginase DeficiencyR01NS110596 · NINDS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI LIPSHUTZ, GERALD S · 2019 to 2023
$1.7M
NICHD NIH HHS P50 HD103557NIH/NINDS R01NS110596NINDS NIH HHS R01 NS110596
6 · The paper itself

Abstract

Altered GABAergic transmission has been implicated in the neurological symptoms of metabolic disorders associated with guanidino compound (GC) accumulation. Building on previous findings that selected GCs act as direct orthosteric GABAA​ receptor (GABAR) agonists, we now asked whether these GCs act preferentially on high-affinity extrasynaptic δ subunit-containing receptors (δ-GABAs). Using whole-cell patch clamp recordings from mouse cerebellar granule cells (CGCs) in brain slices of wild-type and δ-subunit knockout (δ-KO) mice, together with 5 nM [³H]muscimol displacement assays on WT and δ-KO forebrains, we compared the actions of four structurally GABA-like GCs — guanidinoacetate (GAA), β-guanidinopropionate (β-GPA), guanidinoethanesulfonate (GES), and γ-guanidinobutyrate (γ-GBA). These compounds activated CGC GABARs in cumulative concentration-response curves and displaced the highly δ-GABAR-selective ligand [3H]muscimol suggesting δ-GABAR-selective orthosteric agonist actions. In δ-KO forebrains, total [³H]muscimol binding was reduced by ~ 50%, confirming the loss high-agonist-affinity but low-abundance (~ 5% of total forebrain GABARs) δ-GABARs. δ-KO CGCs showed markedly reduced agonist sensitivity, with EC₅₀ values (µM, WT/δ-KO): GABA (2/6) < β-GPA (3/8) < GAA (4/14) < GES (32/72) < γ-GBA (44/219). The modest loss of agonist sensitivity for GABA and the four GABA-mimetic GCs in δ-KO CGCs is consistent with compensatory upregulation of non-δ extrasynaptic GABARs containing only α and β subunits, as previously described (Tretter et al., JBC 2001), explaining the preserved tonic inhibition in δ-KO neurons. Our findings demonstrate that GABA-mimetic GCs preferentially target δ-GABARs and suggest that homeostatic compensation by αβ-type GABARs is a key adaptive mechanism maintaining inhibitory tone in δ-KO CGC neurons.

Indexed as

GuanidinesHomeostasisNeuronsReceptors, GABA-AAnimalsCerebellumDose-Response Relationship, DrugGlycineMaleMiceMice, Inbred C57BLMice, KnockoutMuscimolPatch-Clamp TechniquesProsencephalonGlycineglycocyamineGuanidinesMuscimolReceptors, GABA-AExtrasynaptic GABAA receptorsGABAA receptorGABA-mimeticsGuanidinoacetateGuanidinopropionate

Identifiers

PMID41372746
PMCPMC12801676

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.